MediWales Review - Autumn 2008

W A L E S

m e d i c a

s p e c i a l

W A L E S

m e d i c a

s p e c i a l

Medica 19-22 November 2008 - Messe Dusseldorf, Germany

The Welsh Pavilion: Hall 16 Stand 39 This MediWales Review ‘Medica Special’ is your introduction to the thriving medical technology sector in Wales. It includes a directory of all of those companies involved in the IBW trade mission and pavilion at Medica 2008 as well as a snapshot of some of the most exciting products and services being offered by Welsh companies in this sector.

Medica is the world’s largest medical trade fair and runs alongside the leading international fair for medical manufacturing supplies, ComPaMED. MEDICA and ComPaMED together will occupy all 18 halls of the Düsseldorf Exhibition Centre and organisers expect over 4,300 exhibitors.

MEDICA covers the entire range of out-patient and in-patient healthcare, including: electrical medicine/medical devices ● laboratory technology/ diagnostics ● physiotherapy/ orthopaedic technology ● medical supplies (essential supplies and consumables) ● information and communication technology ● textiles ● medical furniture ● furnishings ● facility management ● building services.

At the same time, ComPaMED addresses all aspects of supplies to the medical manufacturing sector: raw materials ● components ● parts ● packaging ● services for use in medical device production.

International Business Wales (IBW) is the Welsh Assembly Government’s international trade and investment arm, forming part of the Department of Innovation, Enterprise and Networks. It acts as the driving force in establishing alliances

between companies in Wales and their counterparts overseas. At the same time IBW actively seeks out inward investment opportunities for client companies looking to Europe and the UK as a preferred international business location.

The Welsh Assembly Government is a democratically elected body, which was established in May 1999.

It has devolved powers and responsibilities for developing and implementing policies in Wales on a broad range of issues, including economic development, education, the environment, agriculture, housing, roads and transport. The Welsh Assembly works closely with the UK Parliament in developing primary legislation and has powers to introduce secondary legislation of its own.

Contents Global Expertise Wales Pavilion Directory

4 10-17

Bioctalysts

18

Boots Centre for Innovation

19

GX Group

20

Invitron

23

JRBiomedical

24

PDR

25

MediWales has been active for over sixteen years and is the representative body for the medical sector in Wales. Supported by the Welsh Assembly Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales. MediWales generates a unique environment for networking, collaboration and communication between industry, higher education and heath service members. This is delivered through an active schedule of seminar events and publications, supported by the MediWales website and maintained via constant communication with members and stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.

M E M B E R

5 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ T/F: 029 2047 3456 Email: debbie.laubach@mediwales.com coralie.palmer@mediwales.com gwyn.tudor@mediwales.com jess.fisher@mediwales.com Web:

www.mediwales.com

MediWales is a founder member of Medilink UK, the network of regional medical technology organisations that represents the interests of around 3000 organisations across the UK.

MediWales Chairman: Mr Greg Baily, Huntleigh The MediWales Medica Special is published by Teamworks Design Consultants

4

W A L E S

5

m e d i c a

s p e c i a l

GLOBAL EXPERTISE

From local to global Diverse, densely networked and highly responsive, the health technology sector in Wales continues to build on an international reputation for premium products and leading-edge research. Clinical and

life science institutions of international standing work alongside a thriving mix of businesses, from the smallest spinouts and start-ups through SMEs to the largest global corporations.

The latter include a number of internationally renowned names, and the Welsh health technology market has seen this presence augmented by significant mergers and acquisitions in recent years.

Such activity is a marker for investment in expertise, development and growth, as well as a viable exit strategy for founders and early investors.

It is these positive outcomes that are consistently prevalent in the Welsh regional economy, where global parent companies are increasingly investing in Welsh health technology businesses and maintaining that commitment. Last year, for example, saw the acquisition of Huntleigh Technology by ARJO International, creating a leading corporation on the world stage with a comprehensive product portfolio under the ARJOHuntleigh brand.

ARJO manufactures and distributes an ever-increasing range of patient handling, bathing, disinfecting and hydrotherapy equipment, while Huntleigh Healthcare has long been one of the major companies in pressure area care and hospital beds, as well as being a world leader in hand-held dopplers. Huntleigh’s R&D function is concentrated at its Cardiff site, which has seen substantial investment in new facilities, jobs, and equipment. It will continue to take the lead in R&D within the new company structure: ARJOHuntleigh’s new WoundASSIST Topical Negative Pressure (TNP) system recently entered a new product segment in the healthcare market.

GE Healthcare is a global health technology company involved in every aspect of patient care from blood tests to MRI machines. Its acquisition of Amersham, a world leader in diagnostic imaging agents and in life sciences, added new highgrowth, high-technology platforms to GE Medical’s diagnostic imaging, healthcare services and IT businesses. Over 500 employees work at the former Amersham’s Cardiff site, and all indications are

that within GE’s internal market the Cardiff facility is winning new business on regular basis and continues to thrive.

Repeatedly we see emerging the same pattern of building up subsidiaries in the Welsh sector.

Ortho-Clinical Diagnostics, a Johnson & Johnson subsidiary, has recently invested in a multi-millionpound facility in Pencoed in South Wales, and will be part of a J&J Comprehensive Care Group focusing on the care of chronic conditions.

Global healthcare technology company ConvaTec, formerly one of the Bristol-Myers Squibb group and recently acquired by Avista Capital Partners, specialises in wound care products and employs over 1000 people in Wales: it is investing £20 million to expand its South Wales manufacturing facility in addition to its very large North Wales site.

Meanwhile, working at the other end of the company growth cycle, the new Boots Centre for Innovation is supporting start-up and new product development. Based at the Institute of Life Sciences (ILS) in Swansea, the Centre aims to build direct connections between the global retail chemist and grass-roots inventors. Boots has responded to the relentless demand for new overthe-counter products with an ‘open innovation strategy’, establishing a partnership with ILS and venture capitalists Longbow Capital to successfully set up the Centre for Innovation.

Individuals, groups and companies worldwide are actively encouraged to bring innovative potential products

to the Centre, which then supports their development at each stage, aiming ultimately for new consumer products on Boots’ shelves.

IncoStress, a new device to control stress incontinence from Welsh company C&G Medical, has just become the first product to be launched by the Centre and is now available nationwide at Boots.

The capacity for radical innovation is a distinctive feature of the Welsh health technology sector, where established SMEs produce worldclass products using research expertise operating at the frontiers of science. In the small town of Whitland in West Wales, the Magstim Company develops and manufactures its Neurosign and Magstim devices, which enable neuroscientists to work with the human brain in awake subjects.

Neurosign monitors help surgeons locate and monitor motor nerves during surgery, helping to prevent neural damage to the patient in a range of highly sensitive surgical procedures. The Magstim devices are world leaders in the field of magnetic stimulation: the technology uses strong, time-varying magnetic fields generated by a coil held close to stimulation site. The Magstim range is used for research, diagnosis, prognosis and therapy in a range of nervous and psychiatric disorders, and the Magstim Company is in the vanguard of international research into new treatments for depressive disorders.

From its base in Swansea, OsteoTronix has developed a unique technology for the in-vivo delineation

6

7

GLOBAL EXPERTISE

of bodily microstructures. Originally conceived by the company to diagnose bone changes indicating osteoporosis, its newly-christened technique of structural spectroscopy offers a window on a whole range of microstructural changes, particularly those associated with the imminence and growth of cancerous tumours.

This non-invasive, risk-free technology has radical implications for the improvement of diagnosis and monitoring in both acute and chronic diseases, and also for the more rapid and precise development of new drug therapies.

The company’s ground-breaking work has produced a network of collaborations with world leaders in British, European and North American research. OsteoTronix is currently refining both software and hardware products to service the application of its new technology.

Also in Swansea, Haemair has developed a radically new design for an artificial lung. Most conventional treatments for respiratory deficiency force the lungs to keep functioning through mechanically supported breathing and/or oxygen administration. By contrast, the Haemair technology bypasses the lungs altogether, using a hardback book-sized device to exchange oxygen and carbon dioxide directly via the bloodstream. The compact, portable Haemair device is the first to take over ‘breathing’ in this way for conscious and mobile patients, allowing their lungs to rest and recover.

The technology is being developed as a range of models designed to service both acute and chronic lung conditions. In Europe and North America alone, this work offers hope to over a million people a year who currently die of lung disease or damage, and has won the company support and collaboration both nationally and internationally.

Through ongoing prototype development, Haemair is now in a position to complete in-vivo trials: its long-term goal is to establish a viable high-tech manufacturing facility in South Wales to bring this new respiratory aid to a world-wide market.

From the smallest start-up to the largest corporate body, health technology businesses in Wales seem to find here an environment that provides the essential resources they need to thrive. Inventors – from the maverick to the serial expert – can access a vital support network; manufacturers large or small can source a skilled workforce; marketeers have to hand an unrivalled distribution network that can move from local to global. In this fast-moving, highly demanding sector, Welsh capabilities continue to deliver proven benefits that consolidate a leading position in health technology.

9

WALES PAVILION DIRECTORY International Business Wales

Skills and Technology

Jose Constantino Regional Manager - Europe

exceeding your expectations

Welsh Assembly Government Department for the Economy and Transport, Trafalgar House, 5 Fitzalan Place, Cardiff, Wales CF24 0ED United Kingdom Tel: +44 29 2082 8694 Fax: +44 2044 2696 Email: jose.constantino@wales.gsi.gov.uk Web: www.ibwales.com

International Business Wales (IBW) is the Welsh Assembly Government’s international trade and investment arm. It forms part of the Department for the Economy and Transport, and acts as the driving force in establishing alliances between companies in Wales and their counterparts overseas, whilst actively seeking out inward investment opportunities for client companies looking to Europe and the UK as a preferred international business location.

Unit A Kestrel Way Garngoch Industrial Estate Gorseinon Swansea SA4 9WN Tel: 01792 229333 Fax: 01792 897311 Mobile: 0799 062889 Email: karlmorris@bbihealthcare.com Web: www.bbihealthcare.com

BBI Healthcare is a leading provider of diabetes care products to the global market place. As part of the successful BBI Holdings group (BB International, Biozyme, Seravac), the division was set up to source and develop diabetes solutions to complement the group’s range of diagnostic services. Since the South Wales-based healthcare company was established in 2006, it already has a proven track record of commercialising diagnostic and healthcare products to the international market place.

BBI Healthcare is currently looking for European distributors for its glucose tablets and leading GlucoGel brand, which has been widely available through the NHS since 1984.

The company is also seeking new products which can be channelled through a number of territories including UK, Europe, North America and Australasia.

Unit 1, Cefn Coed Parc Nantgarw Cardiff CF15 7QQ Tel: 01443 843712 Fax: 01443 846500 Mobile: 07974 922679 Email: sales@biocats.com Web: www.biocatalysts.com

Biocatalysts Ltd is a specialist enzyme company based in the United Kingdom. It primarily manufactures enzymes for the Food and Diagnostic Kit markets but is different from the majority of enzyme companies in the world market because of its focus on custom-tailoring or developing ‘bespoke’ enzyme systems for individual clients.

Driven by its obsession with superior customer service, Biocatalysts have gained an enviable reputation in the speciality enzyme market. The diagnostic enzyme range covers enzymes to test for a wide range of conditions and full details are available at www.biocatalysts.com.

Jose is in charge of the International Trade activities in the EU markets. He manages a network of business consultants based in key overseas markets and has overall responsibility for delivering IBW’s International Events programme in Europe.

BBI Healthcare

Your integrated electronics manufacturing partner.

Karl John Stanley Morris Sales Manager

• Design capability • PCB assembly • High-level assembly • System configuration • Lean manufacturing • Low cost manufacturing

Biocatalysts Ltd

Stuart West Managing Director

Local solutions from a global manufacturer TT electronics - integrated manufacturing services Tregwilym Industrial Estate Rogerstone, Newport, South Wales NP10 9YA ISO

ISO 1

1:20

01

90

4

00

04

Programme management

NPI

:200

0

Global manufacturing

Tel: +44 (0) 1633 892 345 Email: info.rogerstone@ttelectronics-ims.com www.ttelectronics-ims.com

Full test solution

Design support

10

W A L E S

11

m e d i c a

s p e c i a l

WALES PAVILION DIRECTORY Boots Centre for Innovation

Louise Bryce Marketing Manager

Cellpath Institute of Life Science University of Swansea Singleton Park Swansea SA2 8PP Tel: 01792 513 722 Email: info@bootsinnovation.co.uk Web: www.bootsinnovation.com

Boots Centre for Innovation works closely with early stage companies or inventors to develop innovative new products and technologies within the health and beauty sectors. The principal aim of the Centre is to mentor and support these innovators through each stage of product development and eventually launch exciting new consumer products for the shelves of Boots stores.

At its base in Swansea University, Boots Centre for Innovation provides business knowledge, access to a wealth of scientific expertise, advice on obtaining funding, and a gateway to Alliance Boots international retail network comprising more than 3,200 retail outlets and access to over 135,000 independent pharmacies.

Objectives at Medica Raise awareness of the Boots Centre for Innovation among innovators in the medical product development sector, Attend the Medical Technologies Partnering Event which is being hosted at Medica, to meet with innovative companies who may have products in development which are suitable for Boots stores in the UK and throughout the global Boots distribution network.

Support International Business Wales in attracting new businesses to consider Wales as a potential business location by acting as a magnet for European retail opportunities.

Philip Webber Managing Director Paul Webber Finance Director

Gaynor Morgan CEO

ISO13485:2003-accredited C&G Medicare Ltd was established in 2006 to develop, manufacture and market the multinational awardwinning IncoStress, a non-invasive medical device to control female incontinence. IncoStress was successfully trialled at Singleton Hospital in Swansea under the auspices of Mr Simon Emery. The brand has grown steadily, supplying several of the NHS trusts throughout the UK, as well as other international customers.

C&G Medicare is a dynamic and innovative company expanding its brand by adding new products such as IncoSilk: a new cream successful in treating Intertrigo and other skin conditions.

Objectives at Medica Increase export market by meeting potential and existing suppliers, distributors and customers. Meet potential suitable investors.

David Pascoe

Cardiff Business Technology Centre (CBTC) is one of a family of innovation centres, including Cardiff Medicentre, located in the main bio-cluster of Wales. It is operated in conjunction with Cardiff University, the Welsh Assembly Government, and the Cardiff & Vale National Health Service (NHS) Trust, which operates in the University Hospital of Wales.

The centres provide accommodation for ‘touch-down’ inward investment, for project development and international collaboration, and for new-start businesses with assistance at all stages of the commercial exploitation of new technology. Successful companies include Schlumberger Sema, Portland Hospital, Synexus, British Biocell International, Molecular Light Technology, Trichotech, and Q Chip.

Support overall includes flexible accommodation for international projects, access to the Wales Single Investment Fund (grant aid) for commercial project development, plus Finance Wales investment/topup investment for small start-up projects and business support for novice first-time entrepreneurs. A major redevelopment of the current site is proposed which will provide up to 100,000sq ft of flexible accommodation.

17 Clarion Court Enterprise Park Swansea SA6 8RF Tel: 01792 797910 Fax: 01792 797955 Email: adavidson@dtrmedical.com Web: www.dtrmedical.com

DTR Medical aim to provide medical professionals with high quality single-use sterile disposables that deliver patient and clinical value combined with exceptional levels of service. The company has operated in this market for over three years, during which time it won some 350 new customers.

The range includes sterile single-use disposable surgical instruments and related theatre and clinic products, for specialities including ENT, neurosurgery, vascular and general surgery, and gynaecological procedures. In addition, the company supplies a range of products for sterile services including sterile pre-cut silicone tubing.

Objectives at Medica Recruit distributors Look for additional product opportunities Research export potential for single-use products Meet existing distributors and suppliers

Technium 2 King’s Road Swansea Waterfront Swansea SA1 8PJ Tel: 01792 485660 Web: www.enfis.com

Enfis is a world-class provider and manufacturer of High Power LED light engines and arrays across a wide range of wavelengths; including white light, for use in medical and healthcare applications.

With over 15 international patents, Enfis’s LED products can also be bought globally through distributors such as Silica (www.silicalighting.eu), Digi-Key (www.digi-key.com) and Pacer (www.pacer.co.uk).

Examples of medical applications that have already benefited from Enfis’s high brightness LED lighting products include: Neonatal treatment of Hyperbilirubinemia Operating Room and Examination lighting Dental composite curing

DTR Medical

Enfis Ltd

Cardiff Business Technology Centre Ltd Senghenydd Road Cardiff CF24 4AY Tel: 029 2087 3233 Email: d.pascoe@cardiff.gov.uk Web: www.cbtc.co.uk

Cellpath has established itself as a dynamic innovative company, and has developed an enviable reputation over 25 years for reliability and customer service in its role as market-leading supplier of cellular pathology consumables.

In addition to supplying a comprehensive range of pathology consumables, Cellpath continues to be at the forefront of the design and development of new products. Cellpath has the resources to offer contract manufacturing, processing and packaging, as well as warehouse and distribution for customers looking to outsource these labour-intensive operations.

Objectives at Medica Increase export market by meeting potential and existing suppliers, distributors and customers

Brian Reid Export Sales Manager

C&G Medicare Ltd Russell House 31 Russell Street Swansea SA1 4HR Tel: 0845 2000 761 Email: info@incostress.com Web: www.incostress.com

80 Mochdre Enterprise Park Newtown Powys SY16 4LE Tel: 01686 611333 Fax: 01686 622946 Email: philip@cellpath.co.uk Web: www.cellpath.co.uk

Ali Yilmaz Sales Manager

12

W A L E S

13

m e d i c a

s p e c i a l

WALES PAVILION DIRECTORY Magstim Company Ltd

GX Group

Claire Banks Business Development Manager

The Mayfield Usk Monmouthshire NP15 1SY Tel: 01291 673437 Fax: 01291 673438 Email: claire@gxl.co.uk Web: www.gxl.co.uk

GX is a leading independent design consultancy. We have a proven tract record in high quality design, development and manufacture of instruments, machines and products for the medical sector.

Recent clients include Bayer Diagnostics, Gyrus Medical, Rhytec, CLP, Pall, Medical Support Systems, Morecare and British Gas. Our committed and experienced workforce combine technical excellence and design innovation to meet clients’ needs. Key areas of expertise, all available in-house, include industrial design; mechanical engineering; electronic design; rapid prototyping; optronics design; software design; and CAD animations.

GX Systems also provides high-quality integrated automation and control systems. We have the skills to provide a complete turnkey solution including hardware, control and project management to bring your project in on time. Recent clients include British Airways, Celsa UK, BAAE, Serco, Falkirk CC and Cardiff University. Key areas of expertise, all available in-house, include vehicle location systems; mobile workflow systems; asset management; PLC’s systems; SCADA systems; MES systems; instrument and control panel build; and aftersales support.

Andrew Woodhead Business Development Director

Invitron is a biotechnology company with expertise in the development and manufacture of high-sensitivity in-vitro diagnostics.

As a global supplier of high quality diagnostic tests, Invitron is committed to the continued development of new and innovative products for use in medical and toxicological applications.

Invitron’s products are based on state-of-the-art chemiluminescence technology that has found wide acceptance in clinical laboratories throughout the world. This technology provides a ‘direct labelling system’ that facilitates the development of diagnostic tests with higher sensitivity, better precision and broader working ranges than other immunoassay systems.

Current products include test kits for use in the investigation and monitoring of type 2 diabetes, including immunoassays for the measurement of insulin, C-peptide, intact proinsulin and total proinsulin in human samples. All assays combine the highest attainable performance with simple assay protocols that are quick and easy to use.

Trevor Lewis Principal Consultant

Dr John Rees FIBMS Managing Director

Launching a new product is a challenge for any organisation but for small medical companies the process can be time-consuming, expensive and carry high risks.

JRBiomedical assists organisations both large and small with the development, marketing, launch and distribution of innovative medical devices, diagnostics and services in the UK. Our technical and marketing expertise in both the consumer and professional sectors will free up your existing resources, offering you an affordable and low-risk alternative to licensing or developing a specialist marketing team in-house.

JRBiomedical clients benefit from a rapid route-to-revenue generation, less distraction from core business, revenue streams kept under your control and awardwinning marketing campaigns.

6 Bessborough Drive Cardiff CF11 8NE Tel: 029 2022 1640 Mobile: 07739 733177 Email: lewlink@btclick.com Web: www.medicaldeviceconsultancy.co.uk

Medical Device Consultancy provides specialist business reviews, planning and development consultancy to medical device, in vitro diagnostic (IVD) and related companies, including partner search and selection projects.

Associates have particular strengths in medical device and IVD regulatory compliance for Europe and North America, quality system establishment / improvement, auditing, process, product and software validation, marketing and product management. Medical Device Consultancy works with specialist associates to provide in-depth assistance with: Strategic business development and marketing advice.

Preparation for regulatory inspections or Notified Body quality system audits.

Regulatory submissions and issues for Europe and North America.

Getting your medical device from concept to market – profitably.

Objectives at Medica To meet possible new clients and associates.

Unit 19, Manor Industrial Estate Bagllit Flintshire CH6 5UY

Medical Gas Solutions (MGS) is a supplier and a service organization offering the most innovative, lightweight and user friendly equipment for medical, rescue and emergency applications.

The company offers a complete range of products, including portable inhalers, multi-patient oxygen delivery systems, and most importantly, the lightest-weight cylinder systems available on the market today. MGS are pioneers of ultra-lightweight cylinders filled to 300 bar pressure. This considerably enhances ease of use and longer durations of supply in the field.

MGS has recently been notified by the North West Collaborative Procurement Hub (NWCPH) of their award of a position on the framework agreement for the supply of medical gases and services to Ambulance Trusts. The company has also recently won two new NHS Ambulance Trust’s contracts to supply medical gases for West Midlands Ambulance Service NHS Trust and the North West Ambulance Service NHS Trust.

Medical Gas Solutions Ltd

JRBiomedical Ltd Plas Eirias Business Centre Colwyn Bay LL29 8BF Tel: 01492 510 329 Fax: 08708 362 353 Email: j.rees@jrbiomedical.com Web: www.jrbiomedical.com

Magstim provides the means for neuroscientists to work with the human brain in awake subjects by manufacturing and supplying state-of-the-art clinical and research instruments. Magstim and Neurosign products cover the fields of Neurology, Neurophysiology, Psychiatry and Cognitive Neuroscience as well as ENT, Orthopaedic and Neurosurgery.

Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.

Products are sold directly to hospitals and clinics in the UK and Ireland and exports account for much of the Magstim business. Our principal markets are in Germany, France, Benelux, Japan, the Far East and the USA. Magstim enjoys a close and effective relationship with its specialist distributors and provides significant training and after-sales service.

Medical Device Consultancy

Invitron Limited Wyastone Business Park Wyastone Leys Monmouth NP25 3SR Tel: 01600 891 536 Fax: 01600 891 537 Email: Info@invitron.com Web: www.invitron.com

Spring Gardens Whitland Carmarthenshire SA34 0HR Tel: 01994 240798 Fax: 01994 240061 Email: andrew.thomas@magstim.com Web: www.magstim.com

Darren Allen Sales and Marketing Director

Tel: 01352 736050 Fax: 01352 736059 Mobile: 07912 387855 Email: darren.allen@medicalgassolutions.co.uk Web: www.medicalgassolutions.co.uk

14

W A L E S

15

m e d i c a

s p e c i a l

WALES PAVILION DIRECTORY MediWales Ltd

Qioptiq Limited 5 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ Tel/Fax: 029 2047 3456 Email: debbie.laubach@mediwales.com coralie.palmer@mediwales.com gwyn.tudor@mediwales.com jess.fisher@mediwales.com Web: www.mediwales.com

MediWales is the representative body for the life science and healthcare technology sectors in Wales. With over 100 subscribed members, we are in regular communication with over 1,500 contacts. Supported by the Welsh Assembly Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales.

MediWales delivers a unique environment for networking, collaboration and communication between industry, higher education and health service members. This is achieved through an active schedule of seminar events, publications, website and e-mail with members and stakeholders.

We also play a pivotal role in representing and pursuing the interests of the sector at Welsh and national government level, and on the international stage.

Objectives at Medica I will be available on the Welsh stand to find out more about your business and promote the interests of our members and the sector.

Unit 8, Bretton Farm Offices Chester Road Bretton Chester CH4 0DF Tel: 01244 660954 Fax: 01244 661581 Email:melydadmin@melydmedical.com Web: www.melydmedical.com

Melyd Medical was established in 1995 as a sales and service company, focusing on the operating theatre market and in particular patient positioning. We have had good success acting as the sole distribution outlet for Schaerer Medical (operating tables) within the UK. Further products have been added, including spine positioning systems and other devices from Allen Medical. We also continue to provide Mayfield Neurosurgical products.

Due to expansion we are attending Medica to source potential new partners manufacturing in this field. Of particular interest are products for manual handling used in operating theatre departments, along with new disposable devices. We are also looking for companies to help us develop new devices. Robb Hulson will be available for discussions on the Wales stand.

UWIC Western Avenue Cardiff CF5 2YB Tel: 02920 416725 Fax: 02920 416973 Email: jstephens-pdr@uwic.ac.uk Web: www.pdronline.co.uk

An established and world-renowned centre for innovation, PDR undertakes world class design, engineering and product development support, from conceptual and premarket analysis, right through to detail and tool design to prototype, verification, batch manufacture and product launch.

Combining the latest in research and knowledge with strong commercial discipline, experience and focus, PDR brings together the latest technologies and facilities with experienced, award-winning designers, engineers and technicians, to create unparalleled capability. Both the breadth and depth of experience and capability at PDR is impossible to find in a single location elsewhere in Europe.

PDR has over 13 years extensive experience in the medical sector and has helped many hundreds of companies, from major bluechips to start-ups, to successfully innovate and grow.

Objectives at Medica To strengthen and develop new client relationships To promote PDR’s new service offerings To promote new technologies and processes available in-house at PDR that will benefit product development and innovation in the medical sector

Chris Pye Business Development Manager

Glascoed Road St Asaph Denbighshire LL17 0LL Tel: 01745 588253 Fax: 01745 588354 Email: chris.pye@uk.qioptiq.com Web: www.qioptiq.co.uk

Melyd Medical Ltd

Robb Hulson Managing Director

Silprotect Ltd Unit 8 Ystradgynlais Workshops Ystradgynlais Powys SA9 1BS Tel: 01639 841669 Fax: 01639 841669 Email: david@silprotect.co.uk Web: www.silprotect.co.uk

PDR

Jarred Evans Commercial Director Julie Stephens Commercial Manager

The Qioptiq group is a unique, international network of optics companies addressing defence, aerospace, industrial, medical and scientific markets with optical systems, modules, subassemblies and components.

Group synergies, proven capabilities, customer base and market knowledge have been utilised to develop the compact, high-throughput, automated, electro-optic quality assurance device ‘Microplate Viewer’, Based on the needs of high-throughput laboratories our simple-touse unit is designed to evaluate and store information of cell growth and activity of multiwall plate contents.

Particularly suited to real time viewing of low contrast subjects such as stem cell clusters 15microns our unit offers versatile, high quality image presentation.

Objectives at Medica Promote our interest in developing products for use in the healthcare, Medical technology and laboratory equipment market sectors.

Meet key domestic and international equipment suppliers, users and researchers who may be interested in either our specific product development or general optics capability.

Silprotect Ltd is a privately owned and funded company with technical and manufacturing facilities in Swansea, Wales and Ipswich, England. It was established in 2007 to develop post-manufacturing applied, silver ion-based biocides for use in a wide variety of industries.

Silprotect is now launching its cutting edge range of Bio-ProtectION products at the Medica show. We are looking for technical cooperation and distributors. Our silver ion based products are unique in that they can be applied to any surface to give broad spectrum microbiological protection for up to three months or more, even in high traffic areas.

The Bio-ProtectION range is available in Standard format, which provides long-term durable protection on surfaces; and Instant which includes a non-sticky, water-washable biocide to give 5-minute kill performance. Both products may be combined with our deodorising complex and are available in trigger spray, wet wipe, aerosol and bulk formats.

TT electronics integrated manufacturing services Ltd Tregwilym Industrial Estate Rogerstone Newport NP10 9YA Tel: 01633 892345 Fax: 01633 895755 Email: info@ttems.com Web: www.ttems.com

Delivering electronic manufacturing solutions, as the largest UKowned EMS provider TT electronics is an established manufacturer of electronic & electromechanical assemblies and finished products to the aerospace, defence, telecoms, automotive, medical and industrial sectors.

The complete TT electronics range of value-added services covers design support and process optimisation, turnkey manufacturing and tailored logistics with after-sales support.

In addition TT electronics provides life-cycle cost-efficiency, combining UK-based new product introduction and medium-volume production with high-volume, low-cost manufacture from its own facilities in China and Malaysia, with UK programme management.

TT electronics demonstrates commitment to its customers through the implementation of lean and six-sigma techniques which has led to accreditations including: ISO9001:2000, ISO14001, TS16949 (Automotive) AS9100 (Aerospace) ISO13485 and Kite mark for quality standard IPC-A-610D.

16

W A L E S

17

m e d i c a

s p e c i a l

SHOWCASES Ultrawave Ltd Eastgate Business Park Wentloog Avenue Cardiff CF3 2EY Tel: 0845 330 4236 Fax: 0845 330 4231 Email: admin@ultrawave.co.uk Web: www.ultrawave.co.uk

Ultrawave have been manufacturing precision ultrasonic cleaning equipment for over 15 years for a wide range of industries and applications. In this time, Ultrawave have developed a range of cleaners for healthcare and medical environments including hospitals, sterile service departments and primary care facilities as well as by medical device manufacturers and pharmaceutical companies.

The Hygea range of ultrasonic cleaning baths address modern standards of decontamination and incorporate a locking lid and integral printer for cycle traceability and validation. The Q-Series benchtop ultrasonic baths deliver improved cleaning through Frequency Leap technology and allow digital cycle traceability through an SD card port.

In addition, Ultrawave can offer a range of tailored options, including hollow lumen instrument cleaners and ultrasonic tanks which can be inserted into wet benches. Ultrawave’s precision ultrasonic cleaning equipment is also used in the medical device and pharmaceutical manufacturing industry.

Welsh Wounds Network Wound Healing Research Unit (WHRU) School of Medicine Cardiff University Heath Park Cardiff CF14 4XN Tel: 029 2074 2323 Mob: 07971 231195 Email: clarkm@cardiff.ac.uk Web: www.whru.co.uk Dr Michael Clark Senior Research Fellow

The Welsh Wound Network is a new collaborative organisation dedicated to improving the clinical care of people with wounds in Wales. The network brings together the wealth of academic, clinical and commercial expertise in Welsh wound healing to facilitate the development of new practices and innovations by undertaking high quality collaborative research, audit and other enquiries.

There are several well-known and internationally respected research and clinical groups located in Wales including the Wound Healing Research Unit, the Surgical Materials Testing Laboratory and the All-Wales Tissue Viability Nurse Forum among several others. In this new venture all of these well-established groups have come together to explore areas where collaboration would lead to enhancements in research, practice and commercial innovation. This ongoing communication is supported by a roster of conferences and other networking events throughout the year.

Zoobiotic Ltd Dunraven Business Park Coychurch Road Bridgend CF31 3BG Tel: 0845 2301810 Fax: 01656 668047 Website: www.zoobiotic.com

ZooBiotic Ltd is based in Bridgend, South Wales and manufactures and markets larvae products for the treatment of sloughy and necrotic wounds. All products are produced in accordance with current European ‘Good Manufacturing Practice’ (GMP) requirements in our state-of-the-art aseptic facility. ‘Free range’ LarvE and our BioFOAM dressings are Zoobiotic Ltd’s core products.

BioFOAM dressings consist of larvae that are enclosed in net pouches which contain pieces of hydrophilic polyurethane foam. The BioFOAM dressings can be left on a wound for up to five days. Each dressing is supplied in a plastic oyster as well as a paper/polythene bag which acts as a microbial barrier and is permeable to air.

The ‘free range’ LarvE are applied directly to the wound and seek out areas of slough or necrotic tissue. They are concealed in a net dressing or similar. ‘Free range’ LarvE can be left on a wound for up to three days. LarvE are supplied in a sterile container with a lid that is permeable to air and acts as a microbial barrier.

Biocatalysts Biocatalysts is a wholly independent enzyme manufacturer that operates a unique approach to the manufacture of diagnostic enzymes.

Unlike many manufacturers that produce standard volume commodity enzymes, Biocatalysts work alongside customers to solve their specific process problems and produce custom-made products tailored to their requirements.

Biocatalysts uses a variety of enzyme solutions and our extensive technology and customer-focused approach, combined with the expertise of our scientists, means there are few problems that cannot be solved. For a recent project, Biocatalysts worked with a diagnostic company that had used a local university to produce an E. coli clone, and developed a down-stream processing method based on small quantities of biomass. The medium used animal-based peptones that were not permitted for the commercial product.

Biocatalysts reformulated the medium with non-animal components only, a key part in the product being brought to market. We scaled up the fermentation to a 50-litre fermentation and increased the yield by nearly 100-fold – again, essential in the company achieving their desired profit target. We changed the downstream process so that it could be operated on a larger commercial scale, validated the assay and carried out extensive stability trials to ensure

that the enzyme was fully stable for over two years under the storage conditions desired by the company.

Biocatalysts is known for this attention to detail and ability to deliver technically challenging products.

Dealing with both large blue-chip and small independent companies, Biocatalysts is highly valued for its ability to work on a one-to-one basis.

Expertise is available in fermentation, down-stream processing and enzyme stabilisation. Fermentations from bacteria (E coli and Pseudomonas) and yeast (Saccharomyces and Pichia) are commonplace, from shake flask scale to high-yielding batch fed.

Equipment includes 1-litre and 50litre fermenters with up to 10,000-litre fermentation available. Unlike some companies, Biocatalysts also works regularly with recombinants.

Biocatalysts has an extensive R&D programme focused on the development of new enzymes and enzyme complexes identified to us by our customers. We have many allegiances with leading British universities, where most of our basic research into new enzymes is carried out. This allows us to keep abreast of the very latest developments in bioresearch, while at the same time our in-house scientists can focus on the needs of our customers.

Biocatalysts Ltd Cefn Coed Parc Nantgarw Cardiff CF15 7QQ Tel: 01443 843712 Facsimile: 01443 846500 Email: sales@biocats.com Web: www.biocatalysts.com

18

"OOTS #ENTRE FOR )NNOVATION WAS CREATED IN !PRIL TO WORK CLOSELY WITH EARLY STAGE COMPANIES OR LONE INVENTORS TO DEVELOP INNOVATIVE NEW PRODUCTS AND TECHNOLOGIES FOR THE HEALTH AND BEAUTY RETAIL MARKET

19

4HE PRINCIPLE AIM OF THE #ENTRE IS TO MENTOR AND SUPPORT THESE INNOVATORS THROUGH EACH STAGE OF PRODUCT DEVELOPMENT AND EVENTUALLY LAUNCH EXCITING NEW CONSUMER PRODUCTS EXCLUSIVELY ON THE SHELVES OF !LLIANCE "OOTS STORES "OOTS #ENTRE FOR )NNOVATION WELCOMES ENTREPRENEURS FROM AROUND THE WORLD TO PRESENT THEIR HEALTH AND BEAUTY CONCEPTS FOR CONSIDERATION !T ITS BASE IN 3WANSEA 5NIVERSITY "OOTS #ENTRE FOR )NNOVATION PROVIDES z

"USINESS KNOWLEDGE INCLUDING PRODUCT DEVELOPMENT EXPERTISE MARKETING SKILLS AND GENERAL BUSINESS MANAGEMENT

z

!CCESS TO A WEALTH OF SCIENTIÙC EXPERTISE

z

3UPPORT IN OBTAINING FUNDING

z

! GATEWAY TO !LLIANCE "OOTS INTERNATIONAL RETAIL NETWORK COMPRISING MORE THAN

RETAIL OUTLETS AND PROVIDING ACCESS TO OVER INDEPENDENT PHARMACIES

"OOTS #ENTRE FOR )NNOVATION WILL BE ATTENDING -EDICA ON TH AND ST .OVEMBER AND ARE AVAILABLE ON THE )NTERNATIONAL "USINESS 7ALES STAND % TO MEET ANYONE WHO HAS INNOVATIVE IDEAS IN HEALTH AND BEAUTY )F YOU ARE NOT ATTENDING THE EXHIBITION BUT WOULD STILL LIKE TO SUBMIT AN IDEA PLEASE CONTACT US ON

OR BY EMAIL ON INFO BOOTSINNOVATION COM OR VISIT US AT WWW BOOTSINNOVATION COM

SHOWCASES

Boots Centre for Innovation IncoStress, the revolutionary device designed to control urinary stress incontinence, has been launched by the Boots Centre for Innovation and is now available on sale through the Boots website. The product is the first to be launched by the Centre, a not-for-profit organisation that identifies and helps to develop pioneering products.

Stress incontinence affects more than four million women in the UK and around one-fifth of women worldwide.

Unlike pads, IncoStress controls incontinence by providing support to

WWW BOOTSINNOVATION COM

Firefly Medical Ltd are a new company, whose design team have over 6 years experience in the design, development and regulatory approval of medical equipment.

Our friendly knowledgeable design team are able to identify clients’ milestones in line with ISO 13485:2003, to legally bring CE-marked medical devices into the market.

Utilising our Solid Edge CAD suite we can quickly turn your concepts into 3D models, prototypes and ultimately full production devices. We have proforma regulatory documentation to speed up the development cycle and offer friendly expert advice to assist you in bringing your product to market. We also distribute medical products throughout the U.K with a dedicated sales team and website.

For the avoidance of doubt, Firefly Medical Limited is in no way connected with Williams Medical Supplies Limited. For further information on Williams Medical Supplies Limited please visit www.wms.co.uk�

the bladder and applying a gentle, supporting pressure on the urethra.

The unique shape of the device enables the pelvic floor muscles to work naturally, so helping to improve their strength and tone when used regularly. Made of non-allergenic medical grade silicone, it is worn internally like a tampon and can be used during the day and night for up to eight hours.

from her mother’s experience of stress incontinence, which surgery failed to resolve and for which no comparable device was available.

Both Gaynor and her mother have medical backgrounds and their expertise in physiology, psychology and anatomy helped them achieve a working prototype which was successfully trialled at Swansea’s Singleton Hospital.

IncoStress is the brainchild of Gaynor Morgan, who founded C&G Medical to manufacture the product. The concept of a controlling device arose

Boots Centre for Innovation was approached in October 2007 for support in bringing IncoStress to market. A partnership between

20

W A L E S

21

m e d i c a

s p e c i a l

SHOWCASES

GX Systems Boots, Longbow Capital and the Institute of Life Science at Swansea University, the Centre works closely with early-stage companies or inventors to develop innovative new products and technologies. Offering expertise in all areas of business including product development, marketing and retail know-how, it is able to mentor and support innovators through each stage of the development through to the launch of new products for the shelves of Boots stores.

Since it opened last year the Centre has received more than 700 product ideas from inventors. Gaynor found the Centre to be both a supportive and productive environment: the expertise of its team, particularly in marketing, distribution and packaging, proving invaluable in enabling the IncoStress device to achieve its full product potential.

C&G Medical has grown steadily, supplying and working with several NHS trusts in the UK and several hospitals and pharmacies in Europe.

The ready availability of IncoStress direct to the international customer will bring the benefit of this device to sufferers world-wide. The company is expanding the brand and has just launched their latest development, IncoSilk, a cream formulated to resolve skin complaints such as intertrigo and other fungal infections.

There are more projects in the pipeline, with a very promising future for this young and dynamic company.

Contact: Gaynor Morgan CEO C&G Medicare Ltd 74 Tan y Lan Swansea SA6 7DU Tel: 0845 2000 761 Email: info@incostress.com Web: www.incostress.com Contact: Louise Bryce Marketing Manager Boots Centre for Innovation Institute of Life Science University of Swansea Swansea SA2 8PP Tel: 01792 513722 Fax: 01792 602679 Email: info@bootsinnovation.com Web: www.bootsinnovation.com

GX Systems has supplied the mobile workflow element of the GX Field Service suite of products to Serco, one of the UK’s leading facilities management companies.

Transforming visibility and control over operations, it will provide a direct, up-to-the-minute communication link between Serco’s field service and regional office.

The GX Field Service system is used

by Serco operatives to manage the process of repair and maintenance work across a broad range of service industry situations. It will be used to improve efficiency and cost effectiveness in order for Serco to meet the contractual requirements in place with their clients.

Equipped with handheld PDAs, Serco’s field team send and receive job information as they progress. The information sent to them comes from Serco’s helpdesk when a call is put into the system by the helpdesk operative.

This is then allocated through the GX Field Service system to the field operative best suited to the task, both by skill set and location.

Out in the field, GX Field Service supports individual workers through the delivery of highly flexible workflows on their handheld devices, guiding them through step-by-step procedures for a variety of typical tasks, for example changing or

servicing medical equipment, electrical installations, all of which have been predefined by Serco management.

operatives, but also same-day invoices to customers, cutting paperwork and making major improvements to company cash flow.

Before GX Field Service was implemented, the Serco maintenance team were running a manual, paperbased system which hindered performance measurement and basic management of the maintenance staff. Now Serco’s management team has up-to-the-minute visibility of jobs in progress and the history of activities surrounding each asset through fully secure audit trails. They are able to issue not only instant work instructions to individual field

The system improves both progress reporting and management control, accurately identifying trends and rectifying performance problems through the reporting system. Realtime progress reports can be made and new schedules collected directly from the field. Materials allocation for field operatives is more effectively managed, with updates on stock use made to central stores via PDAs allowing immediate preparation of orders for replacement parts.

22

W A L E S

23

m e d i c a

s p e c i a l

SHOWCASES

Invitron At the same time administration is made simpler and more cost-effective.

The system reduces time spent keying in paper-based information and chasing missing data, and eliminates mistakes due to transcription errors and omissions. Technicians’ labour, material and expense information is taken directly from the field on a per job basis rather than waiting for expense and time sheets.

Through the use of GX Field Service, Serco has raised its profile both in the business community and with their clients by providing a better level of service. Typical applications of GX Field Service include the maintenance of hospital systems, and quality control checks. The system can be tailored to each organisation’s individual needs and GX offers the full back-up support of its highly experienced team of software developers.

Claire banks Business Development Manager GX Group The Mayfield Usk Monmouthshire NP15 1SY Tel: 01291 673437 Fax: 01291 673438 Email: claire@gxl.co.uk Web: www.gxl.co.uk

Given the present global surge in the prevalence of type 2 diabetes, there is increasing pressure for improvements in early diagnosis and management of the disease. Invitron supplies highly sensitive diagnostic test kits that assist in both these areas, providing valuable information in the investigation and monitoring of type 2 diabetes.

It is estimated that approximately 194 million people worldwide have type 2 diabetes and that the prevalence of this disease will more than double by 2030.

The associated healthcare costs have been calculated at around $286 billion worldwide, most of these being linked to the treatment of complications associated with progressive cardiovascular disease.

Patients with impaired glucose tolerance are already at an increased risk of developing cardiovascular disease.

Consequently, both early diagnosis and improved management can influence the outcome of the disease.

The hallmark of type 2 diabetes is insulin resistance. This in its turn leads to fundamental and progressive changes in the secretion of insulin and its precursor molecules (intact and split proinsulins) in the pancreatic β-cell. Accurate data on the secretion of insulin and its related peptides is therefore crucial in facilitating the design and evaluation of new therapies and new drug delivery systems. To aid in this work, Invitron supplies highly sensitive and specific immunoassays for the measurement of insulin, C-peptide, intact proinsulin and total proinsulin in human samples.

Several studies have reported increased circulating concentrations of proinsulin in individuals who are in a pre-diabetic state.

Measurements of proinsulin in at-risk populations may thus prove valuable in the early diagnosis of type 2 diabetes. Recent studies using Invitron products have identified intact proinsulin as a highly specific marker of insulin resistance.

Moreover, it has been observed that while both gliclazide and the insulin-sensitising drug pioglitazone will improve glycaemic control in diabetic subjects, pioglitazone treatment will also reduce proinsulin output, thus lowering the burden on the βcell. It appears therefore that routine measurement of proinsulin concentrations in diabetic patients can contribute to the identification of the most appropriate therapeutic regime.

Invitron’s core technology involves the use of antibodies labelled with chemiluminescent acridinium esters (AE).

This technology provides a platform that combines high sensitivity of detection with simplicity and ease of use, making it the logical alternative to radioisotope labels.

Signal detection is extremely rapid, the light emission from the AE label being complete within 1-2 seconds. As a consequence, a 96-well microtitre plate can be read in less than five minutes using commercially available instruments.

From its base in Monmouthshire, the company supplies customers in Europe, Japan, the USA and Australasia. Invitron highly values its close links with university research departments and is currently supporting academic projects aimed at improving the management of type 2 diabetes in the near future. In addition, the company is actively developing new products that will enhance its reputation as a leading supplier of immunoassay test kits in this important area.

Invitron Ltd Wyastone Business Park Wyastone Leys Monmouth NP25 3SR Tel: 01600 891536 Email: andrew@invitron.com

24

25

W A L E S

m e d i c a

s p e c i a l

SHOWCASES

The National Centre for Product Design and Development Research (PDR)

JRBiomedical Getting a new product to market is a challenge for any organisation but for small medical companies the process can be time consuming, expensive and risky. JRBiomedical assists organisations both large and small with the development, marketing, launch and distribution of innovative medical devices, diagnostics and services in the UK. Unless very fortunate, it is rare for small medical companies to have the appropriate level of in-house expertise needed to bring their latest innovations successfully to market. To overcome these limitations, some may consider licensing to another company with the necessary marketing skills whilst others will invest in developing a specialist marketing team. Both options can turn out to be expensive and each has their own risks.

JRBiomedical offers an affordable, low-risk alternative that allows companies to retain full control.

Established in 2005, JRBiomedical’s growing client base includes the NHS, diagnostic and pharmaceutical companies as well as high street pharmacy retailers. JRBiomedical has helped companies gain distribution through key consumer and professional channels in the UK. Some companies simply require the establishment of a distributor base here in the UK, whilst other projects can be more complex, requiring concept completion, development of marketing plans, product launch and promotion.

A recent JRBiomedical project helped the NHS in Scotland to introduce a new device enabling parents to identify meningitis symptoms at home. From

The National Centre for Product Design & Development Research (PDR) is an award-winning multidisciplinary design and development centre offering a complete service from original research and analysis

One of the companies benefiting from the scheme is Mangar International Ltd, a leading designer and manufacturer of lightweight rehabilitation products. The company, based in Mid Wales, was set up in the early 1980s and employs around 60 staff. The majority of Mangar’s products are powered using lowpressure air and it is the use of this adaptable technology that has given the company its competitive advantage.

intellectual property management.

These new procedures have driven the development of novel, award-winning products.

KTP associate Jon Irlam, supervised

by Dr Richard Bibb from PDR, examined the problems relating to the development of new products. A new “stage gate” design and development process accelerated Mangar’s product development capabilities, enhanced market research activities and improved communications across the various company departments.

The new process facilitated the rapid development of a number of products, most notably the new “Camel” (Complete Air Moving Elevating Lift) device. This innovative technology

through to design, prototyping, manufacture and launch. Up to 67% government funding is available for KTPs, enabling PDR to place highly skilled and experienced graduates in partner companies. Supported and monitored by one of PDR’s qualified experts. These businesses acquire

A two-year KTP between Mangar International and PDR has successfully delivered on two counts.

The collaboration, which involved two KTP associates, produced an innovative rapid product development process and also provided a systematic framework approach to

won the award of “Best New Product 2005” at Medtrade, the world’s largest rehabilitation exhibition in the USA. Mangar are the first European company to have won this award.

Mangar has a rich intellectual property portfolio of over 55 patents registered in the past 25 years. The

PDR is one of the UK’s leading exponents of the Knowledge Transfer Partnerships (KTPs) that allow organisations to access the expertise within PDR, and transfer these capabilities into their own company.

KTPs benefit from substantial government support and have proven to be an excellent way to build a core capability within an organisation that may be difficult to achieve by any other means.

“We were impressed by the fact that you had arranged for the device to be featured on BBC Breakfast.... and that you got the product to market so quickly. Congratulations!” Inventors of the meningitis test, NHS Scotland concept, JRBiomedical co-ordinated the design, development, tooling and manufacture; packaging design and print; meetings with potential customers and patient awareness groups; and distribution of the product, including the media launch and continued high-profile promotion through the pharmacy trade and consumer channels.

The combination of technical and marketing expertise is key to JRBiomedical’s success, along with close working relationships with clients and associates. Out-sourcing commercialisation offers a highly effective alternative to developing specific in-house marketing skills: clients have benefited from awardwinning marketing campaigns year after year. Our expertise frees up existing resources, allowing companies to spend more time on product innovation and development

whilst we focus on the commercialisation. Clients gain a quicker route to revenue generation while keeping revenue streams under their own control.

new specialist knowledge and expertise in the most valuable and cost-effective way, optimizing business potential and promoting growth.

Whether the client is an international organisation or a sole inventor, JRBiomedical helps to get new ideas and innovative products into the market and generates revenue streams quickly.

Dr John Rees FIBMS Managing Director JRBiomedical Ltd Plas Eirias Business Centre Colwyn Bay LL29 8BF Tel: 01492 510 329 Fax: 08708 362 353 Email j.rees@jrbiomedical.com Web: www.jrbiomedical.com

26

W A L E S

company recognised the need to streamline their patents in order to achieve potential cost savings and provide a more systematic approach to product development. KTP associate Chris Bolger, supervised by Dr Huw Millward from PDR, undertook an evaluation of Mangar’s intellectual assets.

New models for the capture and exploitation of intellectual property showed that time and cost savings could be made by rationalising the patent portfolio and putting an early stop to non-viable projects. Mangar’s intellectual property commercialisation is now linked to an

m e d i c a

effective product design process. This has contributed to the successful development and launch of the new Porter Clinical Chair.

The KTP collaboration proved a resounding success and at its conclusion the two associates were offered permanent positions in Mangar’s R&D department. The project exemplified PDR’s ability to bring together the latest technologies and facilities with experienced, award-winning designers, engineers and technicians, combining leadingedge research with strong commercial discipline, experience and focus.

s p e c i a l

PDR The University of Wales Institute Cardiff Western Avenue Cardiff CF5 2YB Tel: 029 2041 6725 Fax: 029 2041 7973 Email: info-pdr@uwic.ac.uk Web: www.pdronline.co.uk Mangar International Presteigne Powys LD8 2UF Tel: 01544 267674 Fax: 01544 260287 Email: marketing@mangar.co.uk Web: www.mangarinternational.co.uk

New Innovations from Welsh Single-use Specialists DTR Medical, the rapidly growing specialist in sterile single-use surgical instruments, have recently launched three products aimed at delivering genuine improvements in performance over traditional products.

The company has also launched two ranges of ear specula; Tumarkin and

with integrated suction for precision nasal work. The development of the Freers pattern blade complete with suction, compliments the highly successful Negus Aspirating Dissector, and enables the Surgeon to easily keep the area clear during the procedure.

Oval are designed to reduce the risk of cross contamination, ensure optimum vision for clinicians and improve patient comfort. The specula have a non-reflective matt finish to reduce glare and are available sterile and non sterile to suit theatre and clinic requirements.

DTR Medical is also launching a sterile single-use Freers ‘Hockey Stick’ Aspirating Dissector to provide first-time optimum instrument quality

The Freer ‘Hockey Stick’ Aspirating Dissector has been designed for single-use, without compromising material quality.

The company is also expanding its general and vascular catalogue, with the addition of a range of Tibbs Arterial Cannula with olives and cones in large and small sizes. These reduce the risk of contamination through flushing and provide a cost effective alternative to re-processing. The Tibbs

Arterial Cannula are manufactured from high quality stainless steel. Each cannula is individually double packed, until ready to use, avoiding wastage and is supplied with two peel-off traceability labels for record use.

DTR Medical provides innovative and high quality sterile single-use instruments to Vascular, Cardiothoracic, ENT, Neurosurgery, and other specialities. The company has cleanroom manufacturing facilities and is accredited to ISO9001:2003. Itconducts CE Marking in compliance with the European Medical Devices Directive MDD93/42/EEC.

DTR 17, Clarion Court, Enterprise Park, Swansea SA6 8RF Tel: +44 (0)1792 797910 Fax: +44 (0)1792 797955 Email: info@dtrmedical.com Web: www.dtrmedical.com